- Report
- February 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- April 2024
- 137 Pages
Global
From €3746EUR$3,899USD£3,203GBP
- Report
- April 2024
- 183 Pages
Global
From €4708EUR$4,900USD£4,025GBP
- Report
- December 2023
- 250 Pages
Global
€4799EUR$4,995USD£4,103GBP
- Report
- February 2024
- 131 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Clinical Trials
- February 2024
- 180 Pages
Global
From €2883EUR$3,000USD£2,464GBP
- Report
- October 2023
- 284 Pages
Global
From €4782EUR$5,151USD£3,950GBP
- Report
- March 2024
- 196 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Clinical Trials
- April 2024
- 240 Pages
Global
From €2883EUR$3,000USD£2,464GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Report
- December 2023
- 115 Pages
Global
From €10564EUR$10,995USD£9,032GBP
- Report
- July 2023
- 242 Pages
Global
From €3459EUR$3,600USD£2,957GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4756EUR$4,950USD£4,066GBP
- Report
- June 2022
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,245GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Report
- May 2021
- 250 Pages
Global
From €8600EUR$8,950USD£7,352GBP
- Report
- June 2022
- 160 Pages
Global
From €7975EUR$8,300USD£6,818GBP
The Age Related Macular Degeneration (AMD) Drug market is a subset of the Optical Disorders Drugs market. AMD is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. AMD is the leading cause of vision loss in people over the age of 50. Treatment options for AMD include drugs, laser therapy, and surgery.
Drugs used to treat AMD include anti-VEGF drugs, which block the growth of abnormal blood vessels in the eye, and corticosteroids, which reduce inflammation. These drugs are typically administered via intravitreal injections.
The AMD Drug market is highly competitive, with a number of companies offering treatments. These include Regeneron Pharmaceuticals, Novartis, Allergan, and Roche. Show Less Read more